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comes on in pro-T cells and will enable the
deletion of Notch1 target genes in pro-T
cells to assess their role in Notch1-
induced lineage fate.
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In this issue of Immunity, Lee et al. (2009) and Wei et al. (2009) each investigate the stability of T helper cell
lineages and find that commitment to these fates is more plastic than previously appreciated.Early studies described CD4+ T cell
effector lineage commitment as a unidirec-
tional process leading to the stable expres-
sion of one of two mutually exclusive cy-
tokine profiles by Th1 and Th2 cells.
However, the description of additional
helper T cell fates has complicated this
model, and in vivo observations of cells
with mixed phenotypes have raised ques-
tions about the stability of helper lineage
fidelity and the relationships among line-
ages. For example: naive CD4+ T cells
differentiate in vitro into Th1 and Th17
effectors that produce IFN-g and IL-17 in
a mutually exclusive manner (at least in
the mouse), but these two cytokines are
often coexpressed in vivo in the context
of infectious or autoimmune diseases
(McGeachy and Cua, 2008); Th17 cells
can express the regulatory T cell-speci-
fying transcription factor Foxp3, whereas
regulatory T cells can be induced to
produce IL-17 (Xu et al., 2007; Yang et al.,
2008); and regulatory T cells can be di-
verted toa Th2 cell lineage if Foxp3 expres-
sion is suppressed (Wan and Flavell, 2007).
Approaching the question of lineage
fidelity from two very different angles, the
papers of Wei et al. (2009) and Lee et al.(2009) demonstrate that T helper cell
lineages retain a surprising degree of
plasticity, which may allow them to adopt
alternative fates or to acquire functions
normally restricted to an opposing CD4+
T cell lineage.
Transcription factors can directly acti-
vate or repress gene expression and
can induce modifications to chromatin
and methylation of DNA at regions where
they bind. These epigenetic modifica-
tions in turn influence the ease with which
transcription factors can bind to their
cognate regulatory sequences and (along
with differences in transcription factor
availability) determine when and to what
extent specific genes are expressed in
a particular cell. Epigenetic modifications
can be inherited through successive cell
divisions, but unlike alterations to the
underlying DNA sequence, they are also
subject to revision in response to
changes in environmental cues. There is
considerable support for the notion that
epigenetic modifications contribute to
the heritability of T helper cell lineage
choice, while implicitly providing the
option for this choice to be subsequently
revised.ImmunityWith this premise in mind, Wei et al.
(2009) set out to explore lineage relation-
ships, commitment, and potential for plas-
ticity in T helper cells. To do so, they used
ChIP-Seq (a technique they helped to
pioneer) to generate complete, compara-
tive genome-wide maps of two informative
and complementary histone modifications
in naive, Th1, Th2, Th17, and induced
(iTreg) and natural regulatory (nTreg)
CD4+ T cells. Trimethylation of lysine 4 on
histone H3 (H3K4me3) is a permissive
mark found at active or poised promoters,
whereas trimethylation of lysine 27 on
histone H3 (H3K27me3) is a mark of
Polycomb-mediated gene silencing. As
expected, enrichment for H3K4me3 corre-
lated perfectly with lineage-appropriate
expression of the genes encoding the cy-
tokines IFN-g, IL-4, IL-17A, and IL-17F
and the transcription factors ROR(g)t and
Foxp3, which help to instruct Th17 and
Treg cell lineage choice, respectively
(Figure 1). However, there was consider-
able heterogeneity as to whether cytokine
or transcription factor genes whose
expression is specific for one effector
lineage were marked by repressive
H3K27me3 in opposing lineages. This30, January 16, 2009 ª2009 Elsevier Inc. 7
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mechanisms to silence gene expression,
such as DNA methylation or H3K9 meth-
ylation, or the intentional absence of
silencing in order to retain the potential for
future expression.
Intriguingly, Tbx21 and Gata3, which
encode the Th1 and Th2 cell lineage-
specifying transcription factors T-bet
and GATA3, respectively, were marked
by H3K4me3 in each of these CD4+ T cell
subsets (Figure 1). H3K4me3 was more
abundant at Gata3 in Th2 and at Tbx21
in Th1 cells, and repressive H3K27me3
was absent, whereas in Th17 cells and in
Treg cells, these genes were marked by
H3K4me3 plus H3K27me3. Genes whose
promoters are marked by these opposing
histone modifications are referred to as
‘‘bivalent’’ and are thought to be poised
for subsequent activation or silencing.
Although it is possible that the retention
of Tbx21 and Gata3 in a poised bivalent
state in Th17 cells and iTreg cells reflects
incomplete differentiation of these cells
over 10 days in polarizing cultures, this
is clearly not the case for nTreg cells.
Further, Wei et al. (2009) demonstrate
the potential for ‘‘lineage reprogramming’’
in nTreg cells, a fraction of which began to
express IFN-g within 72 hr after stimula-
tion in the presence of IL-12.
But what is the raison d’etre for this plas-
ticity? Are Treg cells programmed this way
so that they can serve as surrogate Th1
cells, or might they retain the potential to
turn on T-bet, GATA3, or other lineage-
restricted transcriptional regulators in
order to gain access and thrive at sites
where they help to suppress untoward
Th1 and Th2 responses? Recent work
from the Rudensky laboratory suggests
that the latter may be the case—Treg cells
must express IRF4, which like GATA3 is
essential for Th2 effector differentiation, in
order to suppress Th2-mediated immuno-
pathology (A. Rudensky, personal com-
munication).
When first described, the IL-17-
producing CD4+ T cell subset was thought
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Figure 1. Plasticity and Reciprocity in CD4+ T Cell Lineage Relationships
In additional to the established relationship between naive CD4+ T cell precursors and Th1, Th2, and Th17
T helper cell subsets, recent findings suggest a more plastic set of relationships that allow cells to adopt
overlapping functional profiles or potentially to switch from one lineage to another. This plasticity may be
facilitated by maintaining transcriptional regulators, such as Tbx21 and Gata3, in a poised, bivalent epige-
netic state (i.e., permissive H3K3me3 plus repressive H3K27me3 marks) in opposing lineages, allowing
them to be activated in response to future changes in environmental contexts.8 Immunity 30, January 16, 2009 ª2009 Elsevier Inc.to derive from Th1 cells, thus providing
evidence for functional plasticity within
the Th1 cell lineage. This notion was later
abandoned when Th17 cells were shown
to develop in the absence of T-bet or
STAT4. What remained unexplained was
why mice lacking these transcription
factors are protected from autoimmune
diseases in which Th17 cells are thought
to be centrally involved. The work by Lee
et al. (2009) addresses this conundrum
and the stability of Th17 cell lineage
commitment. By using Th17 cells purified
based on their expression of an IL-17F-
Thy1.1 reporter, they found that Th17 cells
can give rise to cells expressing IL-17 plus
IFN-g (Th17-Th1 cells) or IFN-g alone.
Even after 4 weeks in polarizing culture
conditions, Th17 cells required the
constant presence of TGF-b to sustain
expression of IL-17F and IL-17A, to
silence IFN-g, and to dampen yet never
silence T-bet and IL-12Rb2. Moreover,
IL-12 could suppress the entire Th17 tran-
scriptional program and induce the Th1
program, over time resulting in a popula-
tion of cells functionally indistinguishable
from Th1 cells derived directly from
naive precursors. And in the absence of
TGF-b, IL-23 caused a similar Th17-to-
Th1 shift, with some notable differences,
namely lack of IL-22 and RORa suppres-
sion and with slower kinetics.
Lee et al. (2009) did not address
underlying epigenetic mechanisms, but
as noted above, Wei et al. (2009) found
that Tbx21 is in a bivalent, poised state
in Th17 cells, whereas the Ifng locus
is broadly marked with repressive
H3K27me3. Thus, the common feature of
Th17 cells and nTreg cells found to corre-
late with their residual ability to express
IFN-g was the poised status of Tbx21,
not the state of the Ifng locus. Thus, it
would be of interest to track changes in
epigenetic profiles of Th17 cells as they
acquire Ifng expression to see whether
this and other Th1 loci undergo complete
remodeling such that they are indistin-
guishable from true Th1 cells, or whether
such cells retain evidence of having once
been Th17 cells. Interestingly, the results
of Wei et al. (2009) also provide a sugges-
tion as to why the evolution of Th17 cells
into Th17-Th1 or Th1 cells observed
by Lee et al. (2009) was not recipro-
cated—both the Il17a and Rorc loci
were broadly marked with repressive
H3K27me3 in Th1 cells.
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these two reports comes from cells
generated in canonical culture conditions
in vitro during which they were constantly
exposed to instructive cytokine signals.
In vivo, cells likely receive additional
signals both favoring and opposing Th17
differentiation, and the nature and relative
abundance of these signals, is inconstant.
Thus, an important question is whether
Th17 cells generated in vivo exhibit the
same instability. The evidence at present
is both limited and conflicting. By contrast
to Lee et al. (2009) who purified Th17 cells
based on their expression of an IL-17F-
Thy1.1 reporter, Lexberg et al. (2008) puri-
fied cells from unmanipulated mice based
on their ability to secrete IL-17A directly
ex vivo and found that the fraction of
cells producing IL-17A alone or along
with IFN-g was relatively stable in the
absence of added cytokines for 6 days.
Similarly, when human Th17 cells were
purified from blood based on their ability
to secrete IL-17A directly ex vivo (Streeck
et al., 2008), production of IL-17A
declined and IFN-g increased by 6 weeks
but were considerably more stable than
observed by Lee et al. (2009) whereas An-
nunziato et al. (2007) found that human
Th17 cells cloned directly ex vivo in non-
polarizing conditions can be readilyInterleukin-17A an
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In this issue of Immunity, Ishigame
whereas both IL-17A and IL-17F a
inducing proinflammatory cytokines
Charles Dickens’s epic tale of Paris and
London begins with ‘‘It was the best of
times, it was the worst of times,’’ empha-
sizing the recent advances in wisdom that
coincided with a time of great ignorance.induced to produce substantial amounts
of IFN-g when activated in the presence
of IL-12. Thus, further study will be
required to reconcile these differences,
to determine whether cells that can
produce IL-17A directly ex vivo represent
a relatively more committed subset of
Th17 cells, and to explore the underlying
mechanisms.
In any case, the two reports in this issue
of Immunity indicate that the ability of
CD4+ T cell subsets to adopt alternate or
overlapping fates is determined not
simply by the epigenetic states of cyto-
kine loci but by the epigenetic states of
the entire set of genes associated with
these lineages. Although the data of Wei
et al. (2009) characterized only two
histone modifications, their multilineage
comparison provides hints that global
mapping of histone modifications may
be predictive of lineages that are most
susceptible to deviation and toward
which lineages they are most likely to be
reprogrammed. In the near future, we
can hope to see ever more complete
epigenomic and gene expression profiles
in T helper cell lineages. These profiles
along with data from repolarization studies
as carried out by Lee et al. (2009) should
help to unravel the many unanswered
question regarding T helper cell lineaged Interleukin-17F:
okines
search Center, 530 45th Street, Pittsburgh, PA
s Center, CSRB Room 657, New Orleans, LA 7
et al. (2009) show that interleukin-17
re required for mucosal immunity. IL
.
In the past 10 years, our understanding of
interleukin-17 (IL-17) in mucosal immunity
and autoimmunity has greatly expanded.
IL-17A, the founding member of the
IL-17 family of cytokines, is produced by
Immunitycommitment, plasticity, and overlapping
programs of lineage-restricted gene
expression.
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A (IL-17A) mediates autoimmunity
-17A may be more pathologic by
a subset of CD4+ T cells termed Th17
cells. IL-17A is potent inducer of antimi-
crobial peptides as well as neutrophil
growth factors such as granulocyte
colony-stimulating factor (G-CSF) and it
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